Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Blood pressure drug associated with lower risk of Alzheimer's disease in Black patients

Considering how patients from different ethnic groups respond to the same drug could be crucial to finding new Alzheimer's disease treatments – a disorder the Alzheimer's Association previously deemed a "silent epidemic" among Black adults.

4 Nov 2022

Green tea catechins and resveratrol display neuroprotective properties in Alzheimer's models

In a recent study published in the journal Free Radical Biology and Medicine, researchers screened for neuroprotective compounds against Alzheimer’s disease (AD).

3 Nov 2022

Poll: More than half of people over 50 are a critical source of health help for older loved ones

More than half of people over 50 say they've helped at least one person over 65 take care of their health, personal hygiene, home or finances in the past two years, a new University of Michigan poll finds.

3 Nov 2022

Experts estimate the prevalence of breast cancer survivors in Canada

It was the information she couldn't find that led Amy Kirkham, an assistant professor in the University of Toronto's Faculty of Kinesiology & Physical Education (KPE), to her latest discovery.

3 Nov 2022

Many middle-aged adults unlikely to participate in dementia prevention clinical trials

Right now, drug companies and university-based teams are working urgently to find and test new medications that could prevent or slow the decline of brain function in older adults.

2 Nov 2022

Moderate to heavy drinking could increase the risk of stroke in young adults

People in their 20s and 30s who drink moderate to heavy amounts of alcohol may be more likely to have a stroke as young adults than people who drink low amounts or no alcohol, according to a study published in the November 2, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

2 Nov 2022

First-of-its-kind computer model simulates a clinical trial evaluating two Alzheimer’s drugs

An estimated 6.2 million Americans ages 65 and older are living with Alzheimer's disease. The national Alzheimer's Association predicts that number to grow to 13.8 million by 2060, barring the development of medical breakthroughs that would prevent, slow or cure the debilitating disease.

2 Nov 2022

Researchers corroborate the importance of exercise for cognitive function

Accumulating evidence finds that exercise can improve brain function and delay or prevent the onset of neurodegenerative diseases such as Alzheimer's and Parkinson's disease.

2 Nov 2022

Memory: a revolutionary treatment for mental health disorders and neurodegeneration?

In this interview, we speak to Dr. Steve Ramirez about his latest neuroscience research that investigated the power of our memories.

2 Nov 2022

Hurricane Ian’s deadly impact on Florida seniors exposes need for new preparation strategies

All kinds of natural disasters — hurricanes, tornadoes, floods, wildfires, dangerous heat waves — pose substantial risks to older adults. Yet, not enough seniors prepare for these events in advance, and efforts to encourage them to do so have been largely unsuccessful.

2 Nov 2022

Researchers unravel how the brain chemical dopamine relates to schizophrenia

Researchers at the Lieber Institute for Brain Development (LIBD) believe they have solved a riddle that has challenged scientists for more than 70 years: how the brain chemical dopamine relates to schizophrenia, the often-devastating brain disorder characterized by delusional thinking, hallucinations and other forms of psychosis.

1 Nov 2022

People who had COVID-19 are more vulnerable to developing neurological symptoms

Research led by The University of Queensland has found COVID-19 activates the same inflammatory response in the brain as Parkinson's disease.

1 Nov 2022

COVID-19 presents caregivers with unique challenges not seen in other patients

Roughly 21% of hospitalized COVID-19 patients at the height of the pandemic required an intensive care stay and the bulk were cared for by family upon discharge.

31 Oct 2022

Scientists reveal anti-inflammatory molecules that play an important role in aging

Aging involves complicated plot twists and a large cast of characters: inflammation, stress, metabolism changes, and many others. Now, a team of Salk Institute and UC San Diego scientists reveal another factor implicated in the aging process - a class of lipids called SGDGs (3-sulfogalactosyl diacylglycerols) that decline in the brain with age and may have anti-inflammatory effects.

31 Oct 2022

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Blood pressure drug associated with lower risk of Alzheimer's disease in Black patients

Green tea catechins and resveratrol display neuroprotective properties in Alzheimer's models

Poll: More than half of people over 50 are a critical source of health help for older loved ones

Experts estimate the prevalence of breast cancer survivors in Canada

Many middle-aged adults unlikely to participate in dementia prevention clinical trials

Moderate to heavy drinking could increase the risk of stroke in young adults

First-of-its-kind computer model simulates a clinical trial evaluating two Alzheimer’s drugs

Researchers corroborate the importance of exercise for cognitive function

Memory: a revolutionary treatment for mental health disorders and neurodegeneration?

Hurricane Ian’s deadly impact on Florida seniors exposes need for new preparation strategies

Researchers unravel how the brain chemical dopamine relates to schizophrenia

People who had COVID-19 are more vulnerable to developing neurological symptoms

COVID-19 presents caregivers with unique challenges not seen in other patients

Scientists reveal anti-inflammatory molecules that play an important role in aging

Appel Alzheimer's Disease Research Institute Symposium reveals new developments in dementia research

Study provides new insights into genetic form of frontotemporal dementia

Huntington's disease impairs autophagy in older patients

Proof-of-principle study: Novel tool advances potential way to deliver gene therapy

New discovery may change the textbook model of GPCR-mediated signaling

Strongest evidence to date that lowering blood pressure in later life can cut dementia risk

Innovation in neuroscience drug discovery - eBook eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in